Merck’s $14 Billion Market-Value Plunge Is More Than Last Quarter’s Revenue

(Bloomberg) -- Merck & Co.’s two-day slump has cost the drugmaker almost $14 billion in market value, more than the $11.8 billion it reported in second-quarter revenue.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.